Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 156 shares at $20.00 ($3K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
Scheduled sale ($3k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |